Profiel
James Ballance worked as a Director of Business Development at Aventis Behring from 1999 to 2001.
He was the Vice President of Scientific Affairs at PhaseBio Pharmaceuticals, Inc. in 2013 and 2014.
He was also the Head of Research and Development at Delta Biotechnology Ltd.
Additionally, he worked as the Vice President of Technology Development at BioRexis Pharmaceutical Corp.
from 2003 to 2007.
Dr. Ballance received his undergraduate degree from the University of Wales (Bangor) in 1981 and his doctorate from the University of Bristol in 1984.
Eerdere bekende functies van James Ballance
Bedrijven | Functie | Einde |
---|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Hoofd Techniek/Wetenschap/O&O | 01-12-2007 |
Aventis Behring | Corporate Officer/Principal | 01-01-2001 |
PHASEBIO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van James Ballance
University of Wales (Bangor) | Undergraduate Degree |
University of Bristol | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
Aventis Behring | Health Technology |